Service profile
Black Diamond Therapeutics
Precision oncology biotechnology company engineering small molecule inhibitors targeting oncogenic mutations in EGFR, HER2, and other kinases using allosteric modulation approach for genetically defined tumors with acquired resistance.
About
What Black Diamond Therapeutics is
Precision oncology biotechnology company engineering small molecule inhibitors targeting oncogenic mutations in EGFR, HER2, and other kinases using allosteric modulation approach for genetically defined tumors with acquired resistance.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://blackdiamondtherapeutics.com |
| Status coverage | Public status page |
| Founded | 2014 |
| Headquarters | Cambridge, Massachusetts, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...
Alternatives
